- Location
ovarian cancer
"-
We Really Need to Talk About Bladder Cancer
Mar 5, 2014We really need to talk about bladder cancer Of the top 10 cancers in the UK, bladder cancer is only one where survival rates have been shown to be getting worse. New figures published this month in the Journal of Clinical Urology confirm ...
Tags: Bladder Cancer, Health, Medicine
-
There Are Three Common Drugs for Advanced Ovarian Cancer
Feb 27, 2014There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug can lead to ...
Tags: right drug, sophisticated model of ovarian cancer genetics
-
High Doses of Vitamin C Helped Kill Cancer Cells
Feb 25, 2014Scientists at the University of Kansas Medical Center have determined that high doses of vitamin C, administered intravenously with traditional chemotherapy, helped kill cancer cells while reducing the toxic effects of chemotherapy for some ...
-
Ovarian Cancer After Identifying Two Enzymes That Made It Resistant to Chemotherapy
Feb 7, 2014Queensland scientists have made significant inroads into our understanding of the deadliest form of ovarian cancer after identifying two enzymes that make it resistant to chemotherapy. There is currently no proven screening test or method ...
Tags: QUT, ovarian cancer, Katie Clift, 3D modelling
-
Scientists Say They May Have Found a Way to Predict Survival From Ovarian Cancer
Dec 26, 2013By counting the number of cancer-fighting immune cells inside tumors, scientists say they may have found a way to predict survival from ovarian cancer. The researchers developed an experimental method to count these cells, called ...
-
The Fumbled Debut of The Affordable Care Act, Often Dubbed Obamacare
Dec 26, 2013As 2013 nears to a close, the year's top health news story -- the fumbled debut of the Affordable Care Act, often dubbed Obamacare -- continues to grab headlines. The Obama administration had high hopes for its health-care reform package, ...
-
90%Women Needn't Receive Gene Test to See If They Are at Risk for Breast or Ovarian Cancer
Dec 25, 2013Nine of 10 women do not need and should not receive genetic testing to see if they are at risk for breast or ovarian cancer, an influential panel of health experts announced Monday. The U.S. Preventive Services Task Force (USPSTF) ...
Tags: breast cancer, ovarian cancer, women health, genetic testing
-
23andMe Halted All Marketing Last Week in Accordance with The FDA's Letter.
Dec 4, 2013More than a week after the FDA told 23andMe to stop marketing its Personal Genomic Service tests, the Mountain View, CA–based company says it is complying. "23andMe halted all marketing last week in accordance with the FDA’s ...
-
VBL Therapeutics Has Secured Fast Track Status From The US FDA
Nov 29, 2013VBL Therapeutics has secured fast track status from the US Food and Drug Administration (FDA) for its lead oncology drug VB-111, for prolongation of survival in patients with Recurrent Glioblastoma Multiforme (rGBM). VB-111 was already ...
-
FDA Is Telling 23andMe to Stop Marketing Its Personal Genomic Service Tests.
Nov 27, 2013Posted in Testing Services by Chris Newmarker on November 25, 2013 The FDA is telling 23andMe to stop marketing its Personal Genomic Service tests. The FDA’s move is but another sign that the regulator is increasingly concerned ...
Tags: 23andMe, DNA, Hit, FDA, warning letter
-
FDA Halted The Selling of The 23andMe Saliva Collection Kit
Nov 27, 2013The U.S. Food and Drug Administration halted the selling of the 23andMe Saliva Collection Kit and Personal Genome Service -- a home DNA test. In a letter posted on its website, the FDA alleged 23andMe was being sold without clearance or ...
-
GeneDx Introduced a New Suite of Genetic Tests for Inherited Cancer
Aug 28, 2013GeneDx, a US-based genetic testing laboratory, has introduced a new suite of genetic tests for inherited cancer, including breast and colon cancer. To be marketed under OncoGeneDx brand, the new suite of genetic tests include a 26-gene ...
Tags: Genetic Tests, Inherited Cancer
-
ImmunoCellular Therapeutics Has Obtained US Patent for Methods
May 21, 2013ImmunoCellular Therapeutics has obtained US patent for methods of use of interleukin 13-receptor alpha 2 protein (IL-13Rα2) in cancer immunotherapy. IL-13 is an immune regulatory cytokine and IL-13Ra2 is highly and specifically ...
Tags: Immunocellular, US Patent, Alpha 2 Protein
-
The US Supreme Court Would Rule Against Granting Patents on Human Genes
Apr 18, 2013The US Supreme Court has indicated that they would rule against granting patents on human genes that prevent other researchers to further study the parts of DNA. In 2009, the American Civil Liberties Union and the Public Patent Foundation ...
-
Acceleron Pharma Announced That The Gog Has Sponsored Its Phase 2 Study of Dalantercept
Feb 18, 2013Acceleron Pharma has announced that the Gynecologic Oncology Group (GOG) has sponsored its phase 2 study of dalantercept. Patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer are taking part in the ...
Related Products
-
Wholesale Polyester Ribbon Gift Box Birthday Gift Tanabata Gift Box Packaging Bow Cake Baking Packaging Belt
-
99% Factory Direct Olaparib CAS 763113-22-0 for Anti-Ovarian Cancer with Fast Delivery
-
100% Natural Food Grade 98% Tea Polyphenols UV EGCG Green Tea Extract Herbal Plant with Free Sample
-
Good Quality Olaparib CAS 763113-22-0 with Best Price for Ovarian Cancer
-
Cancer Antigen CA125 (Ovarian Cancer) Group B Monoclonal Antibody
-
China manufacture supply ovarian cancer marker HE4 mAb Antibody
